Description | Value | |
---|---|---|
Number of patients | 6451 | |
Year of diagnosis | Mean (SD) | 2011.5 (2.4) |
Median (IQR) | 2012 (2009-2014) | |
Age | Mean (SD) | 62.2 (14.9) |
Median (IQR) | 62.6 (52.0–72.9) | |
Residence setting | Urban | 5733 (88.9%) |
Rural | 712 (11.0%) | |
Missing | 6 (0.1%) | |
Primary care visits to general practitioner in previous 2 years | Mean (SD) | 3.1 (3.3) |
Median (IQR) | 2 (1–4) | |
Comorbidities | Asthma | 582 (9.0%) |
Congestive heart failure | 301 (4.7%) | |
Hypertension | 2922 (45.3%) | |
Diabetes | 806 (12.5%) | |
Dementia | 164 (2.5%) | |
Number of concurrent medications used | Mean (SD) | 3.9 (3.1) |
Median (IQR) | 3 (2-6) | |
Cancer stage | I | 1140 (17.7%) |
II | 496 (7.7%) | |
III | 2189 (33.9%) | |
IV | 801 (12.4%) | |
Unknown | 1825 (28.3%) | |
Number of CBCs during the observation period | Mean (SD) | 12.0 (16.0) |
Median (IQR) | 6 (2–15) | |
Number of CBCs in the 2 years prior to diagnosis | Mean (SD) | 2.0 (2.8) |
Median (IQR) | 1 (0–3) | |
Number of CBCs in the 2 years after diagnosis | Mean (SD) | 10.0 (15.4) |
Median (IQR) | 4 (1–13) | |
Ovarian cancer death within 3 years of diagnosis | Yes | 2302 (35.7%) |